ReviewBioactive materials2026
Smart biophysical cue-based strategies and materials for intervertebral disc degeneration therapy.
Review in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Low back pain (LBP) is the leading cause of non-fatal disability globally, significantly affecting quality of life and imposing an immense socioeconomic burden. Intervertebral disc degeneration (IVDD) is a major cause of LBP. Although advances in biomaterials and drug delivery have provided new therapeutic options, their efficacy remains limited by invasive delivery approaches and the spatiotemporal dynamic changes in the microenvironment during treatment. In recent years, smart biophysical cue-based strategies-represented by electrical, magnetic, photo, ultrasonic, and mechanical cues-have offered breakthrough noninvasive or minimally invasive approaches for IVDD intervention. Such cues can act directly or indirectly on disc tissues, modulating oxidative stress signaling pathways, optimizing the inflammatory microenvironment, and influencing cellular behavior and extracellular matrix metabolism, thereby delaying or even reversing the degenerative process. These modalities possess highly controllable and precise regulatory potential for tissue repair and can synergize with intelligent biomaterials, drug delivery systems, and other therapeutic strategies to achieve multi-dimensional and multi-targeted regulation. Current research in this field has largely concentrated on isolated biophysical cues or individual material systems, resulting in fragmented advances and a lack of systematic cross-comparison, which limits their translational relevance for precise clinical intervention. This review goes beyond single-cue perspectives to provide a comprehensive and comparative integration of multiple biophysical cue-based strategies and materials within the IVDD field, systematically elucidating their mechanisms of action and developmental trajectories. Moreover, from an interdisciplinary perspective, this review provides new theoretical foundations and directions for precision therapy in IVDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.